Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.465 USD | +5.81% | +8.76% | +12.83% |
05-10 | Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating | MT |
05-10 | Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating | MT |